Literature DB >> 15857023

Lymph node pathway in the spread of endometrial carcinoma.

T Jobo1, R Sato, T Arai, T Tamura, J Watanabe, H Kuramoto.   

Abstract

OBJECTIVE: To elucidate the sentinel nodes of endometrial carcinoma, the spread pathway was clarified. The correlation between lymph node spread and other clinicopathological variables was also analyzed.
METHODS: Dissected lymph node samples in 342 patients who underwent pelvic and selective paraaortic lymphadenectomy were reviewed. Pelvic and paraaortic node (PLN and PAN) status was compared with clinicopathological parameters.
RESULTS: Lymph node metastasis was demonstrated in 52 patients, including 46 cases with PLN metastasis and six patients with independent PAN metastasis. The metastatic sites were most frequent in the obturator and internal iliac nodes. Eleven of 49 patients who underwent PAN dissection were positive for metastasis. Sixteen of 23 cases with parametrial metastasis also metastasized in the retroperitoneal lymph node.
CONCLUSION: The lymph node spread pathway in endometrial carcinoma consists of a major route via the obturator node or internal iliac node with or without parametrial involvement, and rarely a direct PAN pathway.

Entities:  

Mesh:

Year:  2005        PMID: 15857023

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Sentinel lymph node mapping in early stage of endometrial and cervical cancers.

Authors:  Tajossadat Allameh; Vahidehsadat Hashemi; Fereshteh Mohammadizadeh; Fariba Behnamfar
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

2.  The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significance.

Authors:  Jianbin Guo; Haili Qian; Fei Ma; Ying Zhang; Xiujuan Cui; Hua Duan
Journal:  Ther Adv Med Oncol       Date:  2020-06-13       Impact factor: 8.168

Review 3.  PET/CT and cross sectional imaging of gynecologic malignancy.

Authors:  Revathy B Iyer; Aparna Balachandran; Catherine E Devine
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.